NCT04877418

Brief Summary

The current pandemic scenario is immensely challenging for healthcare professionals. Telerehabilitation,is a promising option that benefited many people, allowing continuity of therapeutic processes and promoting the admission of people without prior access to rehabilitation programs. This modality has shown comparable results with conventional rehabilitation strategies, applied in patients with neurological pathologies. However, the modalities applied and the quality of the studies are insufficient to establish their real benefits and effectiveness. Strategies such as CIMT, have been shown to be effective in improving upper limb function and restoring quality of life in stroke survivors. However, there is little evidence on its effectiveness when administered under telerehabilitation modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

May 5, 2022

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

15 days

First QC Date

April 28, 2021

Last Update Submit

November 5, 2022

Conditions

Keywords

TelerehabilitationConstraint Induced Movement therapyUpper limbOutcomesFunctionalityQuality of life

Outcome Measures

Primary Outcomes (1)

  • Upper limb function in patients after stroke.

    MAL: It is a structured interview, composed by 30 items, intended to examine how much and how well the subject uses their more-affected arm outside of the laboratory setting. During the test administration. participants should be told that they can give half scores (i.e., 0.5,1.5,2.5,3.5,4.5) if this is reflective of their ratings. ARAT: It is a performance test that evaluates the ability of the affected upper limb to pick up, move and grasp objects of different size, weight and shape in patients with cortical injury. It is composed of 19 items that examine grip, grip, clamp and gross movement. The total score ranges from 0 (none of the movements were performed) to 57 (all the movements were performed without difficulty). The application of both instruments will be carried out virtually according to standardized procedures.

    3 weeks

Secondary Outcomes (1)

  • The quality of life of patients after stroke.

    3 weeks.

Study Arms (1)

TeleCIMT group

EXPERIMENTAL

One month after baseline evaluations, patients will receive a 3-week program through TeleCIMT. * Task Oriented Repetitive Training * Use of the Affected Upper Extremity * Transfer Package

Procedure: TeleCIMT

Interventions

TeleCIMTPROCEDURE

Mode applied remotely, through the principles and components of the CIMT protocol.

TeleCIMT group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 30 and 80 years.
  • Who present a single stroke event confirmed by CT,
  • Between 5 and 14 points on the NIHSS Scale
  • Who have the ability to sit independently.
  • Who can follow simple instructions (score greater than 13 on the Mini Menta)l.
  • \<2 points on the Modified Ashworth Scale on elbow and wrist
  • \<4 points on the Visual Analog Scale on shoulder.
  • That they can perform a functional test of 20 ° of wrist extension and 10 ° of finger extension (take and drop a cloth with the affected hand).

You may not qualify if:

  • Severe cognitive impairment (aphasia, attention deficit, reasoning or memory disorders).
  • Severe sensory impairment (visual-auditory).
  • Orthopedic limitation (use of a cane).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de La Frontera

Temuco, Chile

Location

Study Officials

  • Arlette Doussoulin, PHD

    Universidad de La Frontera

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 28, 2021

First Posted

May 7, 2021

Study Start

May 5, 2022

Primary Completion

May 20, 2022

Study Completion

August 30, 2022

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

The research team is in talks with their counterpart from the University of Sydney, led by Dr. Lauren Christie, who are developing research on the same topic of study.

Locations